INS and obesity disorder: In humans, euglycemic hyperinsulinemic clamps inhibits secretion of total ghrelin in adults without obesity [38, 39], whereas over a 24-hour period plasma, total ghrelin changes reciprocally with serum insulin in adults without obesity [42].